FEQIX
Price
$79.28
Change
-$0.41 (-0.51%)
Updated
Nov 14 closing price
VVIAX
Price
$68.97
Change
-$0.45 (-0.65%)
Updated
Nov 14 closing price
Ad is loading...

FEQIX vs VVIAX

Header iconFEQIX vs VVIAX Comparison
Open Charts FEQIX vs VVIAXBanner chart's image
Fidelity Equity-Income
Price$79.28
Change-$0.41 (-0.51%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$68.97
Change-$0.45 (-0.65%)
VolumeN/A
CapitalizationN/A
FEQIX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FEQIX vs. VVIAX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEQIX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. FEQIX (8.85B). VVIAX pays higher dividends than FEQIX: VVIAX (2.36) vs FEQIX (1.59). FEQIX was incepted earlier than VVIAX: FEQIX (59 years) vs VVIAX (24 years). FEQIX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (10.00). FEQIX has a lower initial minimum investment than VVIAX: FEQIX (0) vs VVIAX (3000). VVIAX (25.78) and FEQIX (24.58) have marching annual gain over last year. VVIAX return over 5 years is better than : 51.38 vs. FEQIX (40.73).
FEQIXVVIAXFEQIX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence59 years24 years-
Gain YTD19.60718.385107%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.85B184B5%
Annual Yield % from dividends1.592.3668%
Returns for 1 year24.5825.7895%
Returns for 3 years12.5521.8158%
Returns for 5 years40.7351.3879%
Returns for 10 years39.19112.2235%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMV0.370.02
+5.88%
MultiMetaVerse Holdings Limited
PRIM78.91-0.29
-0.37%
Primoris Services Corp
INOD39.16-0.17
-0.43%
Innodata
BCE26.84-0.37
-1.36%
BCE
TLSI4.01-0.49
-10.89%
TriSalus Life Sciences